From WSJopinion: Anthony Fauci’s legacy will be that millions of Americans will never trust government health experts in the same way again
Review & Outlook: CDC director Rochelle Walensky says she’s going to reshuffle the agency with an emphasis on 'action' and 'equity.' Her diagnosis and prescription are both wrong. Images: AP/Reuters/Bloomberg News Composite: Mark KellyAnthony Fauci announced on Monday that he will step down from his National Institutes of Health leadership posts in December, and the fact that this is a major news story suggests the problem with his tenure.
Dr. Fauci has led the National Institute of Allergy and Infectious Diseases since 1984, and his personal research contributions are impressive. He first became known to the public during the early years of the AIDS epidemic, and his agency was an early backer of the mRNA technology that became the platforms for two Covid vaccines.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Myocarditis Risk Higher After COVID-19 Infection than After COVID-19 VaccinationThe risk of myocarditis is substantially higher in the 4 weeks after COVID-19 infection than after a first dose of a COVID-19 vaccine, say researchers of new study. CardioTwitter
Read more »
Long Covid: Mum puts hopes in experimental treatmentKate Stott will travel from Aberdeen to Germany to get experimental treatment for blood microclots.
Read more »
Philippine kids back in school after 2 years lost to COVID-19Millions of students in face masks streamed back to primary and secondary schools across the Philippines for their first in-person classes in two years
Read more »
Pfizer asks FDA to authorize updated COVID vaccine adding protection from Omicron variantsThe FDA ordered vaccine makers to tweak their shots to target BA.4 and BA.5. Pfizer and its partner BioNTech aim to offer updated boosters to people 12 and older, and shots could begin within weeks if the FDA quickly clears the modified vaccine.
Read more »
Pfizer-BioNTech submits new COVID vaccine booster targeting BA.5 to the FDA for authorizationPfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.5 – to the FDA for emergency use authorization.
Read more »